Detectability of auditory evoked response components in preterm infants

Area of Science:

• Neuroscience
• Audiology
• Neonatology

Background:

• Auditory system maturation in preterm infants complicates evoked response detection.
• Detectability of specific evoked response components is crucial for clinical-neurophysiological correlation.
• Low detectability rates can render the absence of a component clinically irrelevant.

Purpose of the Study:

• To determine the detectability and cumulative detectability of auditory evoked responses in preterm infants.
• To assess the clinical utility of different evoked response components based on their detectability.
• To evaluate the impact of repeated testing on improving detectability rates.

Main Methods:

• Longitudinal study of 37 low-risk preterm infants (30-41 weeks conceptional age).
• Recording of auditory brainstem response (ABR), middle latency response (MLR), and auditory cortical response (ACR) components.
• Analysis of detectability and cumulative detectability after one and two recording sessions (approx. 4 weeks apart).

Main Results:

• Evoked response components recorded between 30-34 weeks CA generally have limited clinical use.
• Exceptions include ABR components I, IIn, V, Vc and MLR component Na.
• Cumulative detectability rates improved for all components after two recordings.
• Sufficient cumulative detectability was achieved for ABR (I, II, IIN, III, V, IIc, IIINc, Vc), MLR (Na, P0), and ACR (PbP1, N2p) components.

Conclusions:

• Repeated auditory evoked response testing within approximately 4 weeks significantly improves component detectability in preterm infants.
• Cumulative detectability rates of specific ABR, MLR, and ACR components are sufficient for neurophysiological assessment of the central auditory pathway.
• Early-term components (30-34 weeks CA) have limited clinical value, except for select ABR and MLR components.